Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response

Lancet

Volumn 356, Issue 9248, 2000, Pages 2144-2148

  Leckie, Margaret J ^a   Ten Brinke, Anneke ^b   Khan, Jamey ^a   Diamant, Zuzana ^b   O’xonnor, Brian J ^a   Walls, Christine M ^c   Mathur, Ashwini K ^c   Cowley, Hugh C ^c   Chung, K Fan ^a   Djukanovic, Ratko ^d   Hansel, Trevor T ^a   Holgate, Stephen T ^d   Sterk, Peter J ^b   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; INTERLEUKIN 5; MEPOLIZUMAB; MONOCLONAL ANTIBODY; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; EOSINOPHIL; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 6644229440     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03496-6     Document Type: Article

References (34)

1. Eosinophilic inflammation in asthma
2. Human eosinophils
3. Human eosinophil granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation
4. Airway wall remodelling in asthma
5. Interleukin-5, eosinophils and disease
6. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung
7. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations in interleukin-5
8. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma
9. The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5
10. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
11. Interleukin-5 and the interleukin-5 receptor: Targets for drug discovery in asthma
12. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs
13. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
14. American thoracic society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
15. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide
16. 2-agonists in asthma
17. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum
18. Comparison of incremental and bolus dose inhaled allergen challenge in asthmatic patients
19. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics
20. Reproducibility of allergen-induced early and late asthmatic responses
21. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation
22. Effect of cyclosporin A on the allergen-induced late asthmatic reaction
23. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
24. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects
25. The relationship between inflammation and hyperreactivity of the airways in asthma
26. Allergic networks regulating eosinophilia
27. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma
28. TRFK-5 reverses established airway eosinophilia but not establised hyperresponsiveness in a murine model of chronic asthma
29. Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats
30. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in balb/c mice independently of IL-4 and IL-5
31. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
32. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: Results of a factor analysis
33. Late asthmatic reaction induced by T cell peptides are not associated with eosinophil infiltration of the bronchial mucosa
34. Results of a phase 1 trial with SCH55700, a humanized anti-IL-5 antibody, in severe persistent asthma